FDA Adverse Event Injury Summary report: N

FW,BPB #2 SUTR,BLU W/NDL

MDR report key: 8649287 · Received May 29, 2019

Report

Report Number
1220246-2019-01113
Event Type
Injury
Date Received
May 29, 2019
Date of Event
April 16, 2019
Report Date
May 29, 2019
Manufacturer
ARTHREX, INC.
Product Code
GAT
UDI-DI
00888867041264
PMA / PMN Number
K122374
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MT, US
Reporter Occupation
501

Narratives

Additional Manufacturer Narrative · 1

THE CONTRIBUTION OF THE DEVICE TO THE REPORTED EVENT COULD NOT BE DETERMINED AS THE DEVICE WAS NOT RETURNED FOR EVALUATION. THE DEVICE WAS REPORTED TO HAVE BEEN DISCARDED. THE ROOT CAUSE OF THE EVENT COULD NOT BE DETERMINED FROM THE INFORMATION AVAILABLE AND WITHOUT DEVICE EVALUATION.

Description of Event or Problem · 1

IT WAS REPORTED DURING A REVISION TRICEP REPAIR PROCEDURE, IT WAS DISCOVERED THAT THERE WAS ABNORMAL CELLULAR GROWTH AND PATHOLOGIES AROUND THE SITE WHERE THE IMPLANTED SUTURES (AR-7200, FIBERWIRE) WERE LOCATED. THE REP STATED IT IS UNKNOWN THE REASON FOR THE REVISION PROCEDURE. THE CONSTRUCT WAS COMPROMISED, AND THERE WAS AN INFECTIOUS REACTION FOUND INTERNALLY. THE REP STATED THERE WAS NOT A REPORT OF THE PATIENT EXPERIENCING TOPICAL REACTIONS PRIOR TO HAVING THE REVISION DONE. THE REP STATED THEY WERE NOT MADE AWARE OF THE SPECIFIC PART NUMBERS THAT WERE IMPLANTED DURING THE PRIMARY PROCEDURE. HOWEVER, THE SURGEON DID STATE THEIR CONCERN WAS WITH THE AR-7200 FIBERWIRE THAT WAS USED TO HOLD THE ANCHORS IN PLACE. THE SURGEON REMOVED THE IMPLANTED AR-7200 DURING THE REVISION PROCEDURE, BUT THE METAL CORKSCREWS REMAINED IMPLANTED. ADDITIONAL INFORMATION RECEIVED ON 05/28/2019: THE FOLLOWING ARTHREX PARTS WERE IMPLANTED DURING THE ORIGINAL DISTAL TRICEPS REPAIR PROCEDURE THAT TOOK PLACE ON (B)(6) 2018: AR-1928SNF-2 // LOT: 10156887, AR-7200 // LOT: UNKNOWN. THE INITIAL AND REVISION PROCEDURE WERE PERFORMED BY TWO DIFFERENT SURGEONS AT DIFFERENT FACILITIES. THE PATIENT STARTED HAVING COMPLAINTS OF MILD PAIN ON (B)(6) 2018, BUT NEVER RETURNED TO THE ORIGINAL SURGEON. THE PATIENT WENT TO THE SECOND SURGEON IN (B)(6) 2018 TO OBTAIN A SECOND OPINION. THE REVISION PROCEDURE WAS THEN PERFORMED ON (B)(6) 2019. CULTURES WERE TAKEN INTRAOPERATIVELY AND CANDIDA PARAPSILOSIS WAS CONFIRMED IN THE JOINT FLUID BUT NOT THE TISSUE. THERE WERE NOT ANY ADDITIONAL ARTHREX PARTS IMPLANTED DURING THE REVISION PROCEDURE. THE EXPLANTED FIBERWIRE WAS DISCARDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
442515 FW,BPB #2 SUTR,BLU W/NDL SUTURE, NONABSORBABLE, SYNTHETIC, POLYETHYLENE GAT ARTHREX, INC. FW,BPB #2 SUTR,BLU W/NDL UNK 00888867041264

Patients

Seq Age Sex Outcome Treatment
1 Other